• 1
    Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course. J. Am. Acad. Child Adolesc. Psychiatry 1995; 34: 454463.
  • 2
    Davanzo PA, McCracken JT. Mood stabilizers in the treatment of juvenile bipolar disorder. Advances and controversies. Child Adolesc. Psychiatr. Clin. N. Am. 2000; 1: 159182.
  • 3
    Geller B, Cooper TB, Sun K et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J. Am. Acad. Child Adolesc. Psychiatry 1998; 37: 171178.
  • 4
    Strober M, Morrell W, Burroughs J, Lampert C, Danforth H, Freeman R. A family study of bipolar I disorder in adolescence. Early onset of symptoms linked to increased familial loading and lithium resistance. J. Affect. Disord. 1988; 15: 255268.
  • 5
    Kafantaris V, Coletti DJ, Dicker R, Padula G, Pollack S. Are childhood psychiatric histories of bipolar adolescents associated with family history, psychosis, and response to lithium treatment? J. Affect. Disord. 1998; 51: 153164.
  • 6
    Biederman J, Mick E, Bostic J et al. The naturalistic course of pharmacologic treatment of children with maniclike symptoms: A systematic chart review. J. Clin. Psychiatry 1998; 59: 628637.
  • 7
    Kowatch RA, Suppes T, Carmody TJ et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry 2000; 39: 713720.
  • 8
    Frazier JA, Meyer MC, Biederman J et al. Risperidone treatment for juvenile bipolar disorder: A retrospective chart review. J. Am. Acad. Child Adolesc. Psychiatry 1999; 38: 960965.
  • 9
    DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM. A double blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J. Am. Acad. Child Adolesc. Psychiatry 2002; 41: 12161223.
  • 10
    Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: Reliability, validity and sensitivity. Br. J. Psychiatry 1978; 133: 429435.
  • 11
    Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. Neuropsychopharmacology 2002; 26: 530536.
  • 12
    Tohen M, Jacobs TG, Grundy SL et al. Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch. Gen. Psychiatry 2000; 57: 841849.
  • 13
    Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: A double-blind randomized controlled trial. Clin. Neuropharmacol. 1998; 21: 176180.
  • 14
    Kupka RW, Nolen WA, Altshuler LL et al. The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatments. Br. J. Psychiatry Suppl. 2001; 41: S177S183.
  • 15
    Brown D, Silverstone T, Cookson J. Carbamazepine compared to haloperidol in acute mania. Int. Clin. Psychopharmacol. 1989; 4: 229238.
  • 16
    Greil W, Kleindienst N. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Int. Clin. Psychopharmacol. 1999; 14: 277281.
  • 17
    Cueva JE, Overall JE, Small AM, Armenteros JL, Perry R, Campbell M. Carbamazepine in aggressive children with conduct disorder: A double-blind and placebo-controlled study. J. Am. Acad. Child Adolesc. Psychiatry 1996; 35: 480490.
  • 18
    Geller B, Zimerman B, Williams M et al. DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. J. Child Adolesc. Psychopharmacol. 2002; 12: 1125.
  • 19
    Keck PE Jr, Nabulsi AA, Taylor JL et al. A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder. J. Clin. Psychiatry 1996; 57: 213222.
  • 20
    Spencer TJ, Biederman J, Wozniak J, Faraone SV, Wilens TE, Mick E. Parsing pediatric bipolar disorder from its associated comorbidity with the disruptive behavior disorders. Biol. Psychiatry 2001; 49: 10621070.
  • 21
    Biederman J, Munir K, Knee D et al. High rate of affective disorders in probands with attention deficit disorder and in their relatives: A controlled family study. Am. J. Psychiatry 1987; 144: 330333.
  • 22
    West SA, McElroy SL, Strakowski SM, Keck PE Jr, McConville BJ. Attention deficit hyperactivity disorder in adolescent mania. Am. J. Psychiatry 1995; 152: 271273.
  • 23
    Winokur G, Coryell W, Endicott J, Akiskal H. Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression). Am. J. Psychiatry 1993; 150: 176181.
  • 24
    Kutcher S, Robertson HA, Bird D. Premorbid functioning in adolescent onset bipolar I disorder: A preliminary report from an ongoing study. J. Affect. Disord. 1998; 51: 137144.
  • 25
    Faraone SV, Biederman J, Mennin D, Wozniak J, Spencer T. Attention-deficit hyperactivity disorder with bipolar disorder: A familial subtype? J. Am. Acad. Child Adolesc. Psychiatry 1997; 36: 13781387.
  • 26
    Wozniak J, Biederman J, Mundy E, Mennin D, Faraone SV. A pilot family study of childhood-onset mania. J. Am. Acad. Child Adolesc. Psychiatry 1995; 34: 15771583.